Related Experiment Video
Updated: May 8, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Metabolic bone disease: a continued challenge in extremely low birth weight infants
Sreekanth Viswanathan1, Wasim Khasawneh2, Kera McNelis3
1Division of Neonatology, Department of Pediatrics, Rainbow Babies & Children's Hospital, University Hospitals, Cleveland, OH, USA.
Insights
Metabolic bone disease (MBD) affects nearly one-third of extremely low birth weight (ELBW) infants, often linked to lower nutrient intake and increased medical interventions. This condition is associated with higher mortality and longer hospital stays in these vulnerable infants.
Area of Science:
- Neonatalogy
- Pediatric Endocrinology
- Nutritional Science
Background:
- Metabolic bone disease (MBD) is a significant complication in premature infants, particularly those with extremely low birth weight (ELBW).
- Research on MBD in ELBW infants is limited despite their high risk.
- Understanding MBD incidence and risk factors in ELBW infants is crucial for improving outcomes.
Purpose of the Study:
- To determine the incidence of MBD in extremely low birth weight (ELBW) infants.
- To identify risk factors associated with MBD development in this population.
- To describe the clinical characteristics and outcomes of ELBW infants with MBD.
Main Methods:
- Retrospective analysis of ELBW infants admitted between 2005 and 2010, surviving over 8 weeks.
- MBD diagnosis based on radiographic evidence of osteopenia or rickets.
- Comparison of clinical characteristics, nutrient intake, and outcomes between infants with and without MBD.
Main Results:
- The incidence of radiological MBD was 30.9% (71/230) in ELBW infants.
- Infants with MBD were smaller, more premature, and had higher rates of mechanical ventilation, chronic lung disease, and prolonged parenteral nutrition.
- Lower intake of calcium, phosphorus, vitamin D, protein, and calories was observed in MBD cases, associated with increased mortality and hospital stay.
Conclusions:
- MBD remains a prevalent issue in ELBW infants, even with advancements in neonatal nutrition.
- Factors such as prematurity, low birth weight, and specific medical interventions are linked to MBD.
- Optimizing chronic lung disease management and early nutritional strategies is essential for reducing MBD in ELBW infants.
Background:
Metabolic bone disease (MBD) is an important prematurity-related morbidity, but remains inadequately investigated in extremely low birth weight (ELBW) infants, the group most at risk. The objective was to describe the incidence and associated risk factors of MBD in ELBW infants.
Methods:
Retrospective analysis of all ELBW infants admitted between January 2005 and December 2010 who survived > 8 weeks. MBD was defined as the presence of osteopenia or rickets in radiographs.
Results:
Of the 230 infants included in the study, 71 (30.9%) developed radiological evidence of MBD (cases) of which 24/71 (33.8%) developed spontaneous fractures. MBD and fractures were noted at mean postnatal ages of 58.2 ± 28 and 100.0 ± 61 days, respectively. Compared with controls, cases were smaller at birth (664.6 ± 146 g vs 798.1 ± 129 g), more premature (25.0 ± 1.8 vs 26.4 ± 1.9 weeks), more frequently associated with mechanical ventilation, chronic lung disease, parenteral nutrition days, cholestasis, furosemide, postnatal steroids, and antibiotics use (all P < .01). Cases had lower average weekly intake of calcium, phosphorous, vitamin D, protein, and calories during the first 8 weeks of life compared with controls. Cases with MBD, compared with controls, had higher mortality (14.1 vs 4.4%) and longer hospital stay (140.2 ± 51 vs 101.0 ± 42 days; P < .01).
Conclusions:
MBD remains an important morbidity in ELBW infants despite advances in neonatal nutrition. Further research is needed to optimize the management of chronic lung disease and early nutrition in ELBW infants.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Chronic Kidney Disease II: Clinical Manifestations
What is the Skeletal System?
The Functions of the Skeletal System

